CorMedix Inc. (CRMD)

NASDAQ

$7.32

$-0.16

(-2.09%)

Pre-Market

CorMedix Inc. (CRMD) Live Price Chart

Last updated: ⁦2026-10-13 09:18:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

CorMedix Inc. (CRMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.32, with a market capitalisation of $575.23M and a P/E ratio of 3.11. Over the past 52 weeks, its price has ranged from $6.13 to $13.02. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$575.23M
Open	$7.47
Day's High	$52.00
Day's Low	$0.73
Previous Close	$7.46
Volume	38.00
Average Volume	1.09M
P/E Ratio	3.11
52-Week High	$13.02
52-Week Low	$6.13
Dividend Yield	--
Earnings Date	--

CorMedix Inc. (CRMD) Pre-Market Stock Price

CorMedix Inc. (CRMD) is trading at $7.32 in pre-market trading as of 2026-10-13 09:16:00, down 1.93% ($0.14) from the previous close of $7.46

Pre-market trading shows how investors are pricing CRMD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

CorMedix Inc. (CRMD) 7-Day Stock Price Change

Over the past seven days, CorMedix Inc. (CRMD) moved from $7.19 to $7.32, representing a gain of 1.75% ($0.13).

The stock traded between $7.06 and $7.60 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 1.11 million shares, up versus the previous seven-day period, indicating higher trading activity.

CRMD 52-Week Price Position

Position in Range: 17.3%

52W Low$6.13

52W High$13.02

CRMD is currently trading at $7.32, placing it 17.3% of the way from its 52-week low of $6.13 to its 52-week high of $13.02. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is CorMedix Inc. (CRMD)?

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

CorMedix Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	191
Exchange	NASDAQ
Company Website	https://www.cormedix.com

How to Buy CorMedix Inc. (CRMD) Stock on MEXC

Eligible investors can buy real shares of CorMedix Inc. (CRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRMD and Place Your Order

Open the RealStocks trading page and search for CRMD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is CorMedix Inc. (CRMD) stock price today?

CorMedix Inc. (CRMD) is currently trading at $ 7.32, down 1.93% ($0.14) from the previous close of $ 7.46. Intraday prices update in real time during regular trading hours.

2.Is CRMD stock going up or down today?

As of 2026-10-13 09:16:00, CRMD is trading at $ 7.32, down 1.93% ($0.14) from its previous close of $ 7.46. The stock has traded between $ 0.73 and $ 52.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRMD pre-market price?

As of 2026-10-13 09:16:00, CRMD is trading at $ 7.32 in pre-market trading, down 1.93% ($0.14) from the previous close of $ 7.46. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRMD after-hours price?

As of 2026-10-13 09:16:00, CRMD is trading at $ 7.47 in after-hours trading, up 0.07% ($0.00) from the regular-session close of $ 7.46. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRMD stock trading now?

CRMD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRMD sit relative to its 52-week high and low?

Over the past 52 weeks, CRMD has traded between a low of $ 6.13 and a high of $ 13.02. At $ 7.32, the stock is positioned 17.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is CorMedix Inc. in?

CorMedix Inc. (CRMD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is CorMedix Inc.'s market capitalisation and where is it listed?

CorMedix Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 575.23M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRMD valued in terms of P/E ratio and EPS?

CRMD trades at a P/E ratio of 3.11, based on trailing-twelve-month EPS of $ 2.40. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does CorMedix Inc. pay a dividend?

CorMedix Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.